August 2, 2010

NBJ interviews Metagenics' Jeff Katke at the 2010 NBJ Summit

[video: id=streamhoster-http://web18.streamhoster.com/pentonmedia/npi/clasonde/9510d830-6b6e-4288-afd2-3124c01a64c0.flv, thumb=http://web18.streamhoster.com/pentonmedia/npi/clasonde/634163682395746071.jpg]

Metagenics is already seeing a wide range of tangible benefits following the substantial ownership investment Alticor injected into the practitioner supplement company one year ago, Metagenics CEO Jeff Katke told Nutrition Business Journal’s Carlotta Mast during the 2010 NBJ Summit. Katke was at the annual CEO gathering to accept an NBJ Deal of the Year award recognizing the Metagenics-Alticor strategic alliance, which Katke said is helping Metagenics reach new international markets and take a bigger bite out of the chronic disease epidemic spreading around the globe.
 

Subscribe and receive the latest updates on trends, data, events and more.
Join 57,000+ members of the natural products community.

You May Also Like